FDA expands authorization for Pfizer’s Covid-19 booster to cover 16- and 17-year-olds

The Food and Drug Administration on Thursday expanded the emergency use authorization for Pfizer and BioNTech’s Covid-19 booster shot to cover 16- and 17-year-olds, making it the only booster shot currently available in the United States for teenagers in this age group.